07 Dec, 2023 11:40 AM
On 25 October 2023, Chimeric Therapeutics Limited (ASX:CHM) (Chimeric or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximately $10 million...read more
15 Nov, 2023 10:31 AM
Following accelerated construction activity, the state-of-the-art Activated Carbon facility in Kentucky, USA is now scheduled to begin commissioning production in January 2...read more
31 Oct, 2023 10:45 AM
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a leading innovator in remote monitoring and healthcare technology, is pleased to provide the following quarterl...read more
31 Oct, 2023 10:37 AM
Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell therapy, is pleased to provide a summary of its activities for the quarter ended 30...read more
02 Oct, 2023 10:48 AM
Investment highlights:
Careteq receives 1,500-unit TEQ-Secure order from ADT New Zealand, a subsidiary of Intelligent Monitoring Group (ASX: IMB)
Delivery expected early November and o...read more
13 Sep, 2023 05:22 PM
Investor webinar with the Principal Investigator of the trial, Dr Abhishek Maiti, to be held at 11am AEST Thursday 14 September. Register here.
Sydney, Australia, 13 September 2...read more